达里多雷克桑:探索其在治疗失眠障碍中的作用
Yaroslav Winter1,2, Dario Arnaldi3,4
1Department of Neurology, Saarland University Medical Center, University of Saarland, Homburg, Germany.
Expert review of neurotherapeutics
|March 12, 2026
概括
达里多雷克桑 (Daridorexant) 是一种双素受体对抗剂,在失眠障碍患者中有效改善睡眠和白天功能. 这种药物具有良好的安全性,使其适合广泛的患者群体,包括老年人.
科学领域:
- 药理学 药理学是指药理学的学科.
- 睡眠医学 睡眠医学
- 临床试验 临床试验
背景情况:
- 失眠障碍是影响睡眠和白天功能的一种普遍疾病.
- 双素受体抗剂 (DORAs) 是一种针对失眠的新疗法.
- 达里多雷克桑特是一种具有独特药理动力学特性的DORA.
研究的目的:
- 审查关于达里多雷克桑在治疗失眠障碍方面的证据.
- 根据临床试验数据总结达里多雷克桑的疗效和安全性.
主要方法:
- 使用PubMed和Embase进行了叙事文献搜索.
- 包括1-4期临床试验和daridorexant的观察性研究的全长出版物.
- 专注于证据评估达里多雷克桑对于失眠障碍管理的证据.
主要成果:
- 达里多雷克桑 (50毫克) 显著,临床上有意义的改善了睡眠和白天的功能.
- 在广泛的成年人群中,在客观和患者报告的睡眠测量中观察到有效性,持续长达1年.
- 减少夜间清醒与改善白天功能相关;注意到一个有利的安全概况,适用于老年人.
结论:
- 达里多雷克桑特是一种有效的治疗失眠障碍,改善睡眠质量和白天的表现.
- 它的优化药理动力学和良好的安全性概况支持其在广泛的患者群体中使用,包括老年人.
- 进一步与现有的催眠药进行对比可能是有必要的.
更多相关视频
04:34Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
1.7K
07:54Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
20.8K
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
770
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
770
Management of Insomnia
758
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
758
Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
Insomnia
566
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
566
Sedatives and Hypnotics: Overview
1.9K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.9K
CNS Depressants: Barbiturates and Benzodiazepines
1.6K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.6K
